Sep 2026· Annals of Biomedical Engineering· 0 citations· 222 references
Medicine
TL;DR
This work highlights strategies specifically designed for epithelial-mesenchymal transition (EMT)-associated CTC phenotypes and explores AI- and IoT-enabled implementations for decentralized oncology, and a comprehensive evaluation of electrochemical approaches for CTC and ctDNA detection.
This review systematically correlates TNBC biomarkers with optimal sensing technologies, emphasizing how biomolecular properties affect sensor selection and performance and emphasizes future integration of biosensors with CTC-derived organoids, microfluidics, AI, and multiplexed detection to enable portable, clinically...
Karim G. Mohammed, M. Abdelgawad, Mohamed S. Attia· Clinica chimica acta; intern...· 0 citations
Key RNA biosensor classes developed for oncology are examined, spanning fluorescence based platforms such as aptamers, FRET probes, and molecular beacons, enzymatic and electrochemical architectures including CRISPR Cas systems and field effect transistors, metabolite responsive designs encompassing riboswitches, RNA t...
A. Gamage, H. Herath, K. D. de Silva et al.· Clinica chimica acta; intern...· 0 citations
This review discusses current breakthroughs in aptamer and peptide functionalized microfluidic biosensors for exosome-based cancer diagnostics, focusing on their translation into POC applications, and highlights present challenges, as well as potential future prospects.
P. Priyanka, S. Hemalatha· Microfluidics and Nanofluidi...· 0 citations
This review summarizes relevant biosensor types, including electrochemical, optical, mass-sensitive, microfluidic, nano-biosensors (recently developed), and hydrogel-based systems with discussion of their underlying analytical principles and performance for clinically important cancer biomarkers.
Triple-negative breast cancer (TNBC) is when the patient does not have the three most targeted molecules (estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 or HER2) and the patient resorts to chemotherapy (cytotoxic), and poor prognosis due to the fact that the three most targeted m...
T. L. Manasa, R. Upadhyay, H. B. Divyashree· International journal of com...· 0 citations
Non-small-cell lung cancer (NSCLC) diagnosis is challenged owing to the need for reliable, non-invasive biomarkers. Circulating cell-free microRNAs (ccf-miRNAs) are promising candidates, but their low levels and short sequences in blood complicate detection. In this study, a novel nano-hybrid fluorescent array was deve...
P. K. Mishra, R. Shandilya, Arpit Bhargava et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.